HealthQuill Articles by: HealthQuill
Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.
Drugs Health Pharma

Exercises help women more than men, cut risk of premature death

HQ Team February 21, 2024: Women stand to benefit more than men when they indulge in physical activities as it lowers the risk

Read More
Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli.
Drugs Health Pharma

Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use

HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory

Read More
A new weapon to kill superbugs may be on the horizon after Harvard researchers created a synthetic compound called cresomycin.
Drugs Health Pharma

Harvard researchers create superbug killer molecule cresomycin

 HQ Team February 20, 2024: A new weapon to kill superbugs may be on the horizon after researchers at the Cambridge, Massachusetts-based Harvard

Read More
US researchers have identified 275 million unreported genetic variants in a quarter of a million volunteers that may help understand genetic influences on health and diseases.
Drugs Health Pharma

US researchers spot 275m new genetic variants, may help treat diseases

HQ Team February 20, 2024: US researchers have identified 275 million unreported genetic variants in a quarter of a million volunteers that may

Read More
Pfizer’s Velsipity, an oral drug to treat inflammatory bowel disease, got approval from the European Commission for patients aged 16 and above, according to a company statement.
Drugs Health Pharma

Pfizer Inc’s oral drug for ulcerative colitis gets approval from the EU

HQ Team February 20, 2024: Pfizer’s Velsipity, an oral drug to treat inflammatory bowel disease, got approval from the European Commission for patients

Read More
About 16% of children or one in six children under two years of age in the Northern Gaza Strip, which has been cut off from aid for weeks, are “acutely malnourished,” according to a WHO report based on data collected in January.
Drugs Health Pharma

Hunger, diseases grip undernourished children, women in Gaza: WHO report

HQ Team February 20, 2024: About 16% of children or one in six children under two years of age in the Northern Gaza

Read More
allergy
Drugs Health Pharma

FDA approves Genetech’s Xolair injection for severe food allergies

HQ Team February 19, 2024: The Food and Drug Administration (FDA) has approved Genetech’s Xolair (omalizumab) injection for severe food allergies in certain adults

Read More
Shingles can strike anywhere on your body and it most often appears as a single stripe of blisters that wraps around either the left or the right side of the human torso. At times the pain is excruciating. 
Drugs Health Medical

Herpes Simplex Virus linked to risk of developing Alzheimer’s

HQ Team February 29, 2024: A long-term study of more than a thousand 70 years old people found that those exposed to the

Read More
Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat melanoma — the most serious form of skin cancer — in adult patients.
Drugs Health Pharma

New drug to fight skin cancer gets nod from US drug regulator

HQ Team February 17, 2024: Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat

Read More
The USFDA has cleared AstraZeneca’s lung cancer drug Tagrisso with chemotherapy for treatment in adult patients.
Drugs Health Pharma

AstraZeneca’s non-small lung cancer therapy gets FDA clearance

HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer.

Read More